Abstract digital waveforms in blue and purple

FDA Drug information

Paclitaxel protein-bound particles for injectable suspension (albumin-bound)

Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)

Paclitaxel protein-bound particles for injectable suspension (albumin-bound) PACLITAXEL 100 mg/20mL Apotex Corp.
Paclitaxel protein-bound particles for injectable suspension (albumin-bound) PACLITAXEL 100 mg/20mL BluePoint Laboratories
Paclitaxel protein-bound particles for injectable suspension (albumin-bound) PACLITAXEL 100 mg/20mL Meitheal Pharmaceuticals Inc.

Learning Zones

Light microscopy of the internal lining of the urinary bladder; haematoxylin and eosin stain

Overview

Managing High-Risk NMIBC

Photo of Prostate cancer cells under microscope, pink and purple tones.

Prostate Cancer Nexus

Cerebellum, Thalamus, Medulla oblongata, Spinal cord and Motor Neuron human under the microscope in Lab. Orange colours

Overview

Chronic Inflammatory Demyelinating Polyneuropathy

Prostatic tissue biopsy; Sections show fatty tissue, neural tissue and muscle tissue; Prostate cancer diagnosis

Learning Zone

HRR mutation testing in mPC

8 year old child with redness and peeling of the skin on the body.

TeaserType Overview

TEASER TITLE Atopic Dermatitis in Paediatric Patients

Illustration; activated mast cell releasing histamine; AI generated

Learning Zone

Chronic Spontaneous Urticaria Academy

Unrecognizable female doctor holding graphic virtual visualization model of Lungs organ in hands. Multiple medical icons on the background.

Learning Zone

Type 2 Inflammation in COPD

Learning Zone

Advances in Lymphoma

Blood clot blocking a blood vessel 3D graphic

Learning Zone

THINK THROMBOSIS: Individualised care

UCB EHSF 2024 teaser tile image of 'medical summit'

Learning Zone

Advances in HS

Learning Zone

Herpes Zoster Learning Zone

Learning Zone

Type 2 Inflammation in Upper & Lower Airway Diseases

Overview

Treatment selection in HIV Learning Zone

Learning Zone

Hidradenitis Suppurativa Academy

Learning Zone

Psoriasis Academy

Learning Zone

Myasthenia Gravis Learning Zone

Learning Zone

Growth Hormone Deficiency

Learning Zone

Alopecia areata Learning Zone

Learning Zone

Severe Asthma Learning Zone

Learning Zone

mCRPC in focus

CMKD, Kidney disease, AI generated image

Learning Zone

Complement-mediated kidney diseases

Myocardium Cardiac muscle fibers banner image

Learning Zone

Pompe Disease: Key findings from WMS 2022

Doctor holding patients hand in consultation

Learning Zone

Supportive care in oncology Learning Zone

Learning Zone

Albumin in fluid management

Learning Zone

Glaucoma Learning Zone

Image of AI generated blood clot formation that would require pharmacological treatments available for various vascular conditions, such as anticoagulants, anti platelet agents, and vasodilators

Learning Zone

Antiplatelet therapy in ACS: Choices and Controversies

patient receiving dialysis, hospital image

Learning Zone

Chronic Kidney Disease Learning Zone

Learning Zone

Hidradenitis suppurativa

Learning Zone

Multiple Sclerosis (MS) Learning Zone

Learning Zone

Lupus Learning Zone

Learning Zone

Inflammatory Bowel Disease Learning Zone

Learning Zone

Diagnosis and management of primary hyperoxaluria type 1

Learning Zone

CDK4/6 inhibitors in breast cancer

Patient and doctor in consultation, advice on tobacco use

Learning Zone

Very Brief Advice for Tobacco Dependency

Learning Zone

Fibrinogen Deficiency in Bleeding Learning Zone

Learning Zone

Oral Anticoagulation Reversal Learning Zone

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.